Lawrence P. Guiheen sold $183k of ADMA
director at ADMA BIOLOGICS, INC.. 9,000 shares at an average of $20.29, traded May 21, 2025, filed May 23, 2025.
Score components
- +15RoleDirector
- +12Trade size$183k at market
- 0Share of holdings soldSold 7.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.1%, 3m -12.8%, 6m -15.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-020376, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 21, 2025 | MOption exercise Common Stock | +7,779 | $5.96 | $46k | 122,609 | May 23, 2025 |
| May 21, 2025 | SOpen-market sale Common Stock | -7,779 | $20.32 | $158k | 114,830 | May 23, 2025 |
| May 22, 2025 | MOption exercise Common Stock | +1,221 | $5.96 | $7,277 | 116,051 | May 23, 2025 |
| May 22, 2025 | SOpen-market sale Common Stock | -1,221 | $20.12 | $25k | 114,830 | May 23, 2025 |
| May 21, 2025 | MOption exercise Stock Option (right to buy)derivative | -7,779 | $0.00 | $0 | 1,221 | May 23, 2025 |
| May 22, 2025 | MOption exercise Stock Option (right to buy)derivative | -1,221 | $0.00 | $0 | 0 | May 23, 2025 |
Related signals
Other insiders at ADMA BIOLOGICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $51k 6,400 shares | +1% | |
| 48Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +2% | |
| 43Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +3% | |
| 12Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $318k 21,000 shares | -1% | |
| 24Weak | ADMA BIOLOGICS, INC. | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | $158k 10,096 shares | -2% | |
| 30Weak | ADMAbuy ADMA BIOLOGICS, INC. | Steve Elms director | $217k 14,000 shares | +1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $338k 21,000 shares | -1% | |
| 6Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $416k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.